LAUNCH: Welcome to the PRIME-ROSE LinkedIn site!

We are excited to be part of the growing DLCT (DRUP-Like Clinical Trial) Community and are looking forward to start working on the implementation of precision medicine for all patients in Europe!

The PRIME-ROSE project is funded by #HorizonEU #MissionCancer, starts July 1, and will run for 5 years. Its aim is to connect open, place-based innovation ecosystems for precision cancer medicine based on DRUP-like clinical trials (DLCTs) in Europe. Each DLCT ecosystem consists of PCM diagnostics, a national DLCT-type trial and support by a multi-stakeholder, pentahelix ecosystem. Connecting DLCT ecosystems will help rapidly spread PCM expertise across Europe and result in more patients having access to PCM. We are excited to get started!